2-amino-benzoxazinone derivatives for the treatment of obesity

The use of a compound comprising formula (I): (I) or a salt, ester, amide or prodrug therof in the inhibition of an enzyme whose preferred mode of action is to catalyse the hydrolysis of an ester functionality, e.g. in the control and inhibition of unwanted enzymes in products and processes. The com...

Full description

Saved in:
Bibliographic Details
Main Authors DUNK CHRISTOPHER ROBERT, DOWNHAM ROBERT, MITCHELL TIMOTHY JOHN, HODSON HAROLD FRANCIS, CARR BEVERLEY JANE, PALMER RICHARD MICHAEL JOHN
Format Patent
LanguageEnglish
Published 16.01.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The use of a compound comprising formula (I): (I) or a salt, ester, amide or prodrug therof in the inhibition of an enzyme whose preferred mode of action is to catalyse the hydrolysis of an ester functionality, e.g. in the control and inhibition of unwanted enzymes in products and processes. The compounds are also useful in medicine e.g. in the treatment of obesity and related conditions. The invention also relates to novel compounds within formula (I), to processes for preparing them and pharmaceutical compositions containing them. In formula (I) A is a 6-membered aromatic or heteroaromatic ring; and R1 is a branched or unbranched alkyl (optionally interrupted by one or more oxygen atoms), alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, reduced aryl, reduced heteroaryl, reduced heteroarylalkyl or a substituted derivative of any of the foregoing groups.
Bibliography:Application Number: US20010901868